Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 6.79539778 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 6.79539778 |
3 | central nervous system myelination (GO:0022010) | 6.27879142 |
4 | axon ensheathment in central nervous system (GO:0032291) | 6.27879142 |
5 | * endocrine pancreas development (GO:0031018) | 5.95127392 |
6 | protein maturation by protein folding (GO:0022417) | 5.08300094 |
7 | glandular epithelial cell differentiation (GO:0002067) | 5.08269358 |
8 | signal peptide processing (GO:0006465) | 5.02944794 |
9 | peptide hormone processing (GO:0016486) | 4.78329021 |
10 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.77846316 |
11 | ER overload response (GO:0006983) | 4.51821730 |
12 | COPII vesicle coating (GO:0048208) | 4.34087988 |
13 | cellular ketone body metabolic process (GO:0046950) | 4.33247233 |
14 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.26114036 |
15 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.25282927 |
16 | positive regulation of insulin secretion (GO:0032024) | 4.08558434 |
17 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.08258533 |
18 | insulin secretion (GO:0030073) | 4.02706447 |
19 | dendritic spine morphogenesis (GO:0060997) | 4.00992687 |
20 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.97253360 |
21 | glycerophospholipid catabolic process (GO:0046475) | 3.94071008 |
22 | positive regulation of glycolytic process (GO:0045821) | 3.90474589 |
23 | ketone body metabolic process (GO:1902224) | 3.81566920 |
24 | sequestering of metal ion (GO:0051238) | 3.74142517 |
25 | regulation of hexokinase activity (GO:1903299) | 3.72559275 |
26 | regulation of glucokinase activity (GO:0033131) | 3.72559275 |
27 | protein retention in ER lumen (GO:0006621) | 3.69573298 |
28 | regulation of insulin secretion (GO:0050796) | 3.65675773 |
29 | fatty acid elongation (GO:0030497) | 3.60296349 |
30 | response to lipoprotein particle (GO:0055094) | 3.58994098 |
31 | negative regulation of JUN kinase activity (GO:0043508) | 3.57960087 |
32 | exocrine pancreas development (GO:0031017) | 3.57942944 |
33 | oligodendrocyte differentiation (GO:0048709) | 3.55506234 |
34 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.51581596 |
35 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.51009393 |
36 | * type B pancreatic cell development (GO:0003323) | 3.44685459 |
37 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.42846449 |
38 | auditory receptor cell differentiation (GO:0042491) | 3.41574702 |
39 | inositol phosphate catabolic process (GO:0071545) | 3.40942971 |
40 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.38444690 |
41 | response to hepatocyte growth factor (GO:0035728) | 3.38444690 |
42 | regulation of peptide hormone secretion (GO:0090276) | 3.36845201 |
43 | magnesium ion transport (GO:0015693) | 3.36540688 |
44 | axon ensheathment (GO:0008366) | 3.35351228 |
45 | ensheathment of neurons (GO:0007272) | 3.35351228 |
46 | proline transport (GO:0015824) | 3.34964158 |
47 | myelination (GO:0042552) | 3.33397671 |
48 | myelin maintenance (GO:0043217) | 3.33052673 |
49 | regulation of peptide secretion (GO:0002791) | 3.32911798 |
50 | dorsal/ventral neural tube patterning (GO:0021904) | 3.29417937 |
51 | cerebellar Purkinje cell layer development (GO:0021680) | 3.28015063 |
52 | negative regulation of protein oligomerization (GO:0032460) | 3.27389904 |
53 | positive regulation of peptide hormone secretion (GO:0090277) | 3.26273638 |
54 | * glandular epithelial cell development (GO:0002068) | 3.23652534 |
55 | positive regulation of peptide secretion (GO:0002793) | 3.22193347 |
56 | positive regulation of nuclease activity (GO:0032075) | 3.20206171 |
57 | chemosensory behavior (GO:0007635) | 3.19977482 |
58 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.18401599 |
59 | eye photoreceptor cell differentiation (GO:0001754) | 3.17708025 |
60 | photoreceptor cell differentiation (GO:0046530) | 3.17708025 |
61 | response to methylmercury (GO:0051597) | 3.15348250 |
62 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.14081235 |
63 | inositol phosphate dephosphorylation (GO:0046855) | 3.14081235 |
64 | negative regulation of glycogen biosynthetic process (GO:0045719) | 3.13019738 |
65 | vesicle coating (GO:0006901) | 3.10840201 |
66 | apical protein localization (GO:0045176) | 3.10117974 |
67 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.08238982 |
68 | detection of calcium ion (GO:0005513) | 3.07810845 |
69 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.07700301 |
70 | regulation of transcription involved in cell fate commitment (GO:0060850) | 3.07636915 |
71 | nucleotide transmembrane transport (GO:1901679) | 3.07144133 |
72 | toxin metabolic process (GO:0009404) | 3.03976445 |
73 | response to dietary excess (GO:0002021) | 3.03814476 |
74 | negative regulation of norepinephrine secretion (GO:0010700) | 3.02751249 |
75 | neuron cell-cell adhesion (GO:0007158) | 3.01905907 |
76 | protein palmitoylation (GO:0018345) | 3.01899568 |
77 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.00572858 |
78 | nodal signaling pathway (GO:0038092) | 3.00399237 |
79 | presynaptic membrane assembly (GO:0097105) | 2.99533847 |
80 | regulation of acrosome reaction (GO:0060046) | 2.98365485 |
81 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.98127790 |
82 | nitric oxide mediated signal transduction (GO:0007263) | 2.97942573 |
83 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.97218668 |
84 | response to redox state (GO:0051775) | 2.96471701 |
85 | positive regulation of meiosis (GO:0045836) | 2.94666555 |
86 | righting reflex (GO:0060013) | 2.94136883 |
87 | regulation of hormone secretion (GO:0046883) | 2.93103393 |
88 | peptide hormone secretion (GO:0030072) | 2.92574295 |
89 | regulation of autophagic vacuole assembly (GO:2000785) | 2.91743035 |
90 | cellular response to vitamin D (GO:0071305) | 2.89996692 |
91 | brain morphogenesis (GO:0048854) | 2.89976388 |
92 | negative regulation of hormone metabolic process (GO:0032351) | 2.89928663 |
93 | asymmetric protein localization (GO:0008105) | 2.89914121 |
94 | response to pheromone (GO:0019236) | 2.89820987 |
95 | regulation of nuclease activity (GO:0032069) | 2.89184386 |
96 | regulation of beta-amyloid formation (GO:1902003) | 2.89005689 |
97 | negative regulation of insulin secretion (GO:0046676) | 2.87469876 |
98 | lactate metabolic process (GO:0006089) | 2.87377918 |
99 | negative regulation of neurotransmitter transport (GO:0051589) | 2.87352944 |
100 | peptide secretion (GO:0002790) | 2.85434467 |
101 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.84658733 |
102 | negative regulation of catecholamine secretion (GO:0033604) | 2.84221074 |
103 | presynaptic membrane organization (GO:0097090) | 2.84037773 |
104 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.83729756 |
105 | cellular response to glucagon stimulus (GO:0071377) | 2.82785487 |
106 | startle response (GO:0001964) | 2.82755175 |
107 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.82712729 |
108 | protein localization to Golgi apparatus (GO:0034067) | 2.82336026 |
109 | macroautophagy (GO:0016236) | 2.81675312 |
110 | creatine metabolic process (GO:0006600) | 2.80894028 |
111 | cellular response to unfolded protein (GO:0034620) | 2.78734466 |
112 | regulation of neurotransmitter uptake (GO:0051580) | 2.78493985 |
113 | protein targeting to Golgi (GO:0000042) | 2.78148632 |
114 | calcium ion import (GO:0070509) | 2.78029967 |
115 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.77972001 |
116 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.76311678 |
117 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.75608022 |
118 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.75033536 |
119 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.74934099 |
120 | urinary tract smooth muscle contraction (GO:0014848) | 2.74211315 |
121 | regulation of peptide transport (GO:0090087) | 2.74018180 |
122 | phenylpropanoid metabolic process (GO:0009698) | 2.73610885 |
123 | cellular response to topologically incorrect protein (GO:0035967) | 2.72738506 |
124 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.72464809 |
125 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.72464809 |
126 | acrosome reaction (GO:0007340) | 2.71858198 |
127 | positive regulation of meiotic cell cycle (GO:0051446) | 2.71145781 |
128 | respiratory chain complex IV assembly (GO:0008535) | 2.69750965 |
129 | ER-nucleus signaling pathway (GO:0006984) | 2.68580695 |
130 | * columnar/cuboidal epithelial cell development (GO:0002066) | 2.68251639 |
131 | * astrocyte differentiation (GO:0048708) | 2.67801178 |
132 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.67406535 |
133 | negative regulation of gluconeogenesis (GO:0045721) | 2.67385597 |
134 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.65845239 |
135 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.65647248 |
136 | negative regulation of glycogen metabolic process (GO:0070874) | 2.64227330 |
137 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.63007257 |
138 | dentate gyrus development (GO:0021542) | 2.62668404 |
139 | alanine transport (GO:0032328) | 2.62308064 |
140 | reflex (GO:0060004) | 2.62246716 |
141 | nephron epithelium morphogenesis (GO:0072088) | 2.61667625 |
142 | nephron tubule morphogenesis (GO:0072078) | 2.61667625 |
143 | adaptation of signaling pathway (GO:0023058) | 2.61327943 |
144 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.58661949 |
145 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.58480901 |
146 | regulation of energy homeostasis (GO:2000505) | 2.57478315 |
147 | pancreas development (GO:0031016) | 2.56810479 |
148 | positive regulation of hormone secretion (GO:0046887) | 2.56282893 |
149 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.56017628 |
150 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.55581724 |
151 | positive regulation of gluconeogenesis (GO:0045722) | 2.55453126 |
152 | neurotransmitter secretion (GO:0007269) | 2.53840797 |
153 | phasic smooth muscle contraction (GO:0014821) | 2.53082225 |
154 | adult feeding behavior (GO:0008343) | 2.52832789 |
155 | polyol catabolic process (GO:0046174) | 2.51277335 |
156 | artery smooth muscle contraction (GO:0014824) | 2.51248123 |
157 | nonmotile primary cilium assembly (GO:0035058) | 2.50860628 |
158 | positive regulation of respiratory burst (GO:0060267) | 2.50550957 |
159 | peptide transport (GO:0015833) | 2.44678576 |
160 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.44508410 |
161 | locomotory exploration behavior (GO:0035641) | 2.44462955 |
162 | positive regulation of neurotransmitter transport (GO:0051590) | 2.43800567 |
163 | oligosaccharide catabolic process (GO:0009313) | 2.43703802 |
164 | neuromuscular process controlling posture (GO:0050884) | 2.43549800 |
165 | kidney morphogenesis (GO:0060993) | 2.43321055 |
166 | * neuron fate specification (GO:0048665) | 2.42866209 |
167 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.42662330 |
168 | glutamate receptor signaling pathway (GO:0007215) | 2.40914970 |
169 | innervation (GO:0060384) | 2.40776857 |
170 | regulation of respiratory system process (GO:0044065) | 2.40250029 |
171 | * epithelial cell fate commitment (GO:0072148) | 2.38716562 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.92922844 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.52991733 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.45784799 |
4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.36605241 |
5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.26456890 |
6 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.21102156 |
7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.02438990 |
8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.02222549 |
9 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.99467913 |
10 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.96618788 |
11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.92933058 |
12 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85706909 |
13 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77442629 |
14 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.74837256 |
15 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.74193805 |
16 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.72544466 |
17 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72056210 |
18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72052761 |
19 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.70545618 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69600267 |
21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64739656 |
22 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.60364749 |
23 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.59864668 |
24 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.59254744 |
25 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58545507 |
26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.58268777 |
27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56467976 |
28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52378868 |
29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.52168287 |
30 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.51710263 |
31 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.50979822 |
32 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50230094 |
33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48668926 |
34 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.46578873 |
35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46182621 |
36 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46033973 |
37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.42332508 |
38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.41060741 |
39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41003635 |
40 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40693581 |
41 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.39877856 |
42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.39515837 |
43 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.35176285 |
44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34788565 |
45 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.34738533 |
46 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.33823839 |
47 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.31460671 |
48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30964659 |
49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30771713 |
50 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.29998383 |
51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29168724 |
52 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28711981 |
53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28618865 |
54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26882532 |
55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26645101 |
56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26098910 |
57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26001845 |
58 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.25992880 |
59 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.25533202 |
60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25164066 |
61 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25049467 |
62 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.23174577 |
63 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.23174577 |
64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23011436 |
65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.22983772 |
66 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19117618 |
67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18928545 |
68 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.18758683 |
69 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18269657 |
70 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18022041 |
71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18022041 |
72 | EWS_26573619_Chip-Seq_HEK293_Human | 1.17890738 |
73 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17660352 |
74 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16125441 |
75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13979395 |
76 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.13522125 |
77 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11923518 |
78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11039160 |
79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.10857809 |
80 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10837356 |
81 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10552108 |
82 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10164503 |
83 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09987364 |
84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09172098 |
85 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09035352 |
86 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.08544280 |
87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08499446 |
88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08342547 |
89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08246186 |
90 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07246062 |
91 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.06177980 |
92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06124493 |
93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05618001 |
94 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05137003 |
95 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04560207 |
96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03621462 |
97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03405550 |
98 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02188887 |
99 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.02031159 |
100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01966024 |
101 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01499089 |
102 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01399798 |
103 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01369343 |
104 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01216378 |
105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00544199 |
106 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00502204 |
107 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00434433 |
108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00302699 |
109 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99995848 |
110 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.99694913 |
111 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.99590656 |
112 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99325531 |
113 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98883984 |
114 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98883984 |
115 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.98230971 |
116 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98008722 |
117 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97147690 |
118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.96814309 |
119 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96765814 |
120 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94925319 |
121 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92854901 |
122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92465647 |
123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92023844 |
124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90175185 |
125 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89424982 |
126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88811037 |
127 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88811037 |
128 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.88555353 |
129 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87535307 |
130 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85576147 |
131 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.84827244 |
132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84626179 |
133 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84449496 |
134 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.83471612 |
135 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82669340 |
136 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82202437 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004043_abnormal_pH_regulation | 4.23728971 |
2 | MP0003283_abnormal_digestive_organ | 4.21569049 |
3 | MP0003787_abnormal_imprinting | 4.13667267 |
4 | MP0003195_calcinosis | 3.54860793 |
5 | MP0000013_abnormal_adipose_tissue | 3.44875981 |
6 | * MP0002693_abnormal_pancreas_physiology | 3.38156058 |
7 | MP0002877_abnormal_melanocyte_morpholog | 3.37827756 |
8 | MP0009780_abnormal_chondrocyte_physiolo | 3.30189807 |
9 | * MP0001944_abnormal_pancreas_morphology | 3.07020657 |
10 | MP0002909_abnormal_adrenal_gland | 3.04064967 |
11 | MP0003183_abnormal_peptide_metabolism | 2.92051823 |
12 | MP0005379_endocrine/exocrine_gland_phen | 2.86393674 |
13 | MP0010234_abnormal_vibrissa_follicle | 2.77903792 |
14 | MP0004270_analgesia | 2.65778128 |
15 | MP0000678_abnormal_parathyroid_gland | 2.47826490 |
16 | MP0008877_abnormal_DNA_methylation | 2.42183094 |
17 | MP0001986_abnormal_taste_sensitivity | 2.37905453 |
18 | MP0000920_abnormal_myelination | 2.36471464 |
19 | MP0010386_abnormal_urinary_bladder | 2.33399337 |
20 | MP0000003_abnormal_adipose_tissue | 2.25551787 |
21 | MP0005220_abnormal_exocrine_pancreas | 2.24924482 |
22 | MP0000462_abnormal_digestive_system | 2.24086123 |
23 | MP0005645_abnormal_hypothalamus_physiol | 2.20013791 |
24 | MP0006072_abnormal_retinal_apoptosis | 2.14860757 |
25 | MP0003122_maternal_imprinting | 1.96957560 |
26 | MP0009046_muscle_twitch | 1.96812576 |
27 | MP0005646_abnormal_pituitary_gland | 1.79137480 |
28 | MP0003172_abnormal_lysosome_physiology | 1.76036286 |
29 | MP0002837_dystrophic_cardiac_calcinosis | 1.75216640 |
30 | * MP0002078_abnormal_glucose_homeostasis | 1.72680176 |
31 | MP0002638_abnormal_pupillary_reflex | 1.64967154 |
32 | MP0005058_abnormal_lysosome_morphology | 1.59616537 |
33 | MP0003121_genomic_imprinting | 1.56512558 |
34 | MP0003123_paternal_imprinting | 1.56261642 |
35 | MP0002876_abnormal_thyroid_physiology | 1.54728866 |
36 | * MP0003634_abnormal_glial_cell | 1.49097167 |
37 | MP0010678_abnormal_skin_adnexa | 1.48058014 |
38 | MP0001968_abnormal_touch/_nociception | 1.47228405 |
39 | MP0000631_abnormal_neuroendocrine_gland | 1.45316536 |
40 | MP0002102_abnormal_ear_morphology | 1.43080502 |
41 | MP0002277_abnormal_respiratory_mucosa | 1.37918910 |
42 | MP0001529_abnormal_vocalization | 1.37533127 |
43 | MP0001485_abnormal_pinna_reflex | 1.34704957 |
44 | MP0003329_amyloid_beta_deposits | 1.34029205 |
45 | MP0000613_abnormal_salivary_gland | 1.33034288 |
46 | MP0003868_abnormal_feces_composition | 1.32183608 |
47 | MP0004885_abnormal_endolymph | 1.31825458 |
48 | MP0001501_abnormal_sleep_pattern | 1.30250367 |
49 | MP0002272_abnormal_nervous_system | 1.30148468 |
50 | MP0001984_abnormal_olfaction | 1.30015702 |
51 | MP0001299_abnormal_eye_distance/ | 1.27848954 |
52 | MP0003690_abnormal_glial_cell | 1.27101233 |
53 | MP0002734_abnormal_mechanical_nocicepti | 1.26859177 |
54 | MP0004742_abnormal_vestibular_system | 1.26607212 |
55 | MP0002896_abnormal_bone_mineralization | 1.26403768 |
56 | MP0004859_abnormal_synaptic_plasticity | 1.23052839 |
57 | MP0001765_abnormal_ion_homeostasis | 1.22649900 |
58 | MP0008961_abnormal_basal_metabolism | 1.20652438 |
59 | MP0004145_abnormal_muscle_electrophysio | 1.19920726 |
60 | MP0003959_abnormal_lean_body | 1.16913434 |
61 | MP0004019_abnormal_vitamin_homeostasis | 1.16574191 |
62 | MP0002234_abnormal_pharynx_morphology | 1.15927802 |
63 | MP0003879_abnormal_hair_cell | 1.15351156 |
64 | MP0002229_neurodegeneration | 1.13378030 |
65 | MP0001502_abnormal_circadian_rhythm | 1.12962719 |
66 | MP0005386_behavior/neurological_phenoty | 1.12586257 |
67 | MP0004924_abnormal_behavior | 1.12586257 |
68 | MP0006276_abnormal_autonomic_nervous | 1.11706644 |
69 | MP0005257_abnormal_intraocular_pressure | 1.11599915 |
70 | MP0005375_adipose_tissue_phenotype | 1.08743167 |
71 | MP0003953_abnormal_hormone_level | 1.08383507 |
72 | MP0000383_abnormal_hair_follicle | 1.08061466 |
73 | MP0004133_heterotaxia | 1.06097619 |
74 | MP0010329_abnormal_lipoprotein_level | 1.04914365 |
75 | * MP0000955_abnormal_spinal_cord | 1.04875597 |
76 | MP0001486_abnormal_startle_reflex | 1.03821522 |
77 | MP0005253_abnormal_eye_physiology | 1.03717940 |
78 | MP0003136_yellow_coat_color | 1.02177895 |
79 | MP0000427_abnormal_hair_cycle | 1.01295732 |
80 | MP0005171_absent_coat_pigmentation | 1.01237732 |
81 | MP0002822_catalepsy | 1.00336968 |
82 | MP0002733_abnormal_thermal_nociception | 0.98540686 |
83 | MP0002938_white_spotting | 0.96360605 |
84 | MP0002064_seizures | 0.95522667 |
85 | MP0003011_delayed_dark_adaptation | 0.95295924 |
86 | MP0004142_abnormal_muscle_tone | 0.94831067 |
87 | MP0004264_abnormal_extraembryonic_tissu | 0.94189294 |
88 | MP0001970_abnormal_pain_threshold | 0.93493066 |
89 | MP0005310_abnormal_salivary_gland | 0.93120847 |
90 | MP0005332_abnormal_amino_acid | 0.92663821 |
91 | MP0000778_abnormal_nervous_system | 0.92020585 |
92 | MP0003633_abnormal_nervous_system | 0.90478206 |
93 | MP0002254_reproductive_system_inflammat | 0.89979624 |
94 | MP0002139_abnormal_hepatobiliary_system | 0.89956255 |
95 | MP0003635_abnormal_synaptic_transmissio | 0.89416152 |
96 | MP0005409_darkened_coat_color | 0.89312303 |
97 | MP0003880_abnormal_central_pattern | 0.89139929 |
98 | MP0005408_hypopigmentation | 0.89029033 |
99 | MP0002572_abnormal_emotion/affect_behav | 0.88428748 |
100 | MP0005174_abnormal_tail_pigmentation | 0.87761348 |
101 | MP0005535_abnormal_body_temperature | 0.87731215 |
102 | MP0002163_abnormal_gland_morphology | 0.87230370 |
103 | MP0002067_abnormal_sensory_capabilities | 0.85477796 |
104 | MP0000569_abnormal_digit_pigmentation | 0.83978802 |
105 | MP0000639_abnormal_adrenal_gland | 0.82645451 |
106 | MP0009643_abnormal_urine_homeostasis | 0.82291664 |
107 | MP0001270_distended_abdomen | 0.81561086 |
108 | MP0002735_abnormal_chemical_nociception | 0.80874910 |
109 | MP0002090_abnormal_vision | 0.80312656 |
110 | MP0003300_gastrointestinal_ulcer | 0.79381163 |
111 | MP0002557_abnormal_social/conspecific_i | 0.79203471 |
112 | MP0005423_abnormal_somatic_nervous | 0.78773652 |
113 | MP0005636_abnormal_mineral_homeostasis | 0.78165971 |
114 | MP0002736_abnormal_nociception_after | 0.77754715 |
115 | MP0002184_abnormal_innervation | 0.77264202 |
116 | MP0001905_abnormal_dopamine_level | 0.76911221 |
117 | MP0001661_extended_life_span | 0.75369382 |
118 | * MP0002882_abnormal_neuron_morphology | 0.74615727 |
119 | MP0005365_abnormal_bile_salt | 0.74174637 |
120 | MP0000230_abnormal_systemic_arterial | 0.73078932 |
121 | MP0001666_abnormal_nutrient_absorption | 0.73043064 |
122 | MP0002928_abnormal_bile_duct | 0.72250315 |
123 | MP0005367_renal/urinary_system_phenotyp | 0.72207561 |
124 | MP0000516_abnormal_urinary_system | 0.72207561 |
125 | MP0002069_abnormal_eating/drinking_beha | 0.71380288 |
126 | MP0002118_abnormal_lipid_homeostasis | 0.71231275 |
127 | MP0008569_lethality_at_weaning | 0.70345927 |
128 | MP0002066_abnormal_motor_capabilities/c | 0.70291613 |
129 | MP0008872_abnormal_physiological_respon | 0.68902557 |
130 | MP0005084_abnormal_gallbladder_morpholo | 0.68332811 |
131 | MP0003631_nervous_system_phenotype | 0.67593743 |
132 | MP0001440_abnormal_grooming_behavior | 0.67327672 |
133 | MP0003045_fibrosis | 0.66906476 |
134 | MP0003632_abnormal_nervous_system | 0.65316051 |
135 | MP0005551_abnormal_eye_electrophysiolog | 0.65223538 |
136 | MP0004134_abnormal_chest_morphology | 0.65124527 |
137 | MP0003119_abnormal_digestive_system | 0.65008903 |
138 | MP0001664_abnormal_digestion | 0.62716002 |
139 | MP0001756_abnormal_urination | 0.61221435 |
140 | MP0005448_abnormal_energy_balance | 0.60648510 |
141 | MP0002063_abnormal_learning/memory/cond | 0.59353304 |
142 | MP0002177_abnormal_outer_ear | 0.59061905 |
143 | MP0004036_abnormal_muscle_relaxation | 0.58992719 |
144 | MP0009745_abnormal_behavioral_response | 0.57610363 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.25042403 |
2 | Hypoglycemic seizures (HP:0002173) | 6.29133999 |
3 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.90762109 |
4 | Symptomatic seizures (HP:0011145) | 5.72997109 |
5 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.94486507 |
6 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.93928698 |
7 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.93928698 |
8 | Large for gestational age (HP:0001520) | 4.93026254 |
9 | Hypoglycemic coma (HP:0001325) | 4.86114394 |
10 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.32075888 |
11 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.23068556 |
12 | Hyperglycemia (HP:0003074) | 4.15274008 |
13 | Hemiparesis (HP:0001269) | 3.79935499 |
14 | Neurofibrillary tangles (HP:0002185) | 3.76893625 |
15 | Ketoacidosis (HP:0001993) | 3.67004925 |
16 | Double outlet right ventricle (HP:0001719) | 3.60003704 |
17 | Congenital malformation of the right heart (HP:0011723) | 3.60003704 |
18 | Dysostosis multiplex (HP:0000943) | 3.57173598 |
19 | Abnormal pancreas size (HP:0012094) | 3.50144704 |
20 | Late onset (HP:0003584) | 3.27500888 |
21 | Decreased circulating renin level (HP:0003351) | 3.25112203 |
22 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.12752117 |
23 | Mucopolysacchariduria (HP:0008155) | 3.12752117 |
24 | Hypokalemia (HP:0002900) | 3.09037374 |
25 | Hyperparathyroidism (HP:0000843) | 3.06933771 |
26 | Enlarged penis (HP:0000040) | 3.06155497 |
27 | Pheochromocytoma (HP:0002666) | 3.05404346 |
28 | Agitation (HP:0000713) | 3.03188874 |
29 | Urethral obstruction (HP:0000796) | 2.94408807 |
30 | Increased circulating renin level (HP:0000848) | 2.94290745 |
31 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.92652063 |
32 | Abnormality of renin-angiotensin system (HP:0000847) | 2.82064372 |
33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.81003033 |
34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.81003033 |
35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.81003033 |
36 | Hypsarrhythmia (HP:0002521) | 2.78047771 |
37 | Anteriorly placed anus (HP:0001545) | 2.77256797 |
38 | EEG with generalized epileptiform discharges (HP:0011198) | 2.75863335 |
39 | Cerebral inclusion bodies (HP:0100314) | 2.74434880 |
40 | Epileptiform EEG discharges (HP:0011182) | 2.61961126 |
41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.61657731 |
42 | Osteomalacia (HP:0002749) | 2.58566204 |
43 | Neuroendocrine neoplasm (HP:0100634) | 2.58558602 |
44 | Congenital sensorineural hearing impairment (HP:0008527) | 2.57844788 |
45 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.56302030 |
46 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.56302030 |
47 | Alacrima (HP:0000522) | 2.56108663 |
48 | Retinal atrophy (HP:0001105) | 2.56055493 |
49 | Neoplasm of the adrenal cortex (HP:0100641) | 2.53262622 |
50 | Abnormality of potassium homeostasis (HP:0011042) | 2.51898149 |
51 | Hamartoma of the eye (HP:0010568) | 2.49335482 |
52 | Abnormal sex determination (HP:0012244) | 2.48510088 |
53 | Sex reversal (HP:0012245) | 2.48510088 |
54 | Conjunctival hamartoma (HP:0100780) | 2.47783168 |
55 | Progressive neurologic deterioration (HP:0002344) | 2.44762235 |
56 | Hyperthyroidism (HP:0000836) | 2.43711488 |
57 | Volvulus (HP:0002580) | 2.43346817 |
58 | Medial flaring of the eyebrow (HP:0010747) | 2.43118972 |
59 | Supranuclear gaze palsy (HP:0000605) | 2.37874232 |
60 | Split foot (HP:0001839) | 2.34745733 |
61 | Congenital glaucoma (HP:0001087) | 2.34207618 |
62 | Abnormality of vitamin B metabolism (HP:0004340) | 2.32748853 |
63 | Cortical visual impairment (HP:0100704) | 2.32141944 |
64 | Conjugated hyperbilirubinemia (HP:0002908) | 2.30875461 |
65 | Hyperventilation (HP:0002883) | 2.28997873 |
66 | Unilateral renal agenesis (HP:0000122) | 2.28779199 |
67 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.28595669 |
68 | Hypokalemic alkalosis (HP:0001949) | 2.27059497 |
69 | Prominent metopic ridge (HP:0005487) | 2.24977852 |
70 | Hypoplasia of the fovea (HP:0007750) | 2.21307963 |
71 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.21307963 |
72 | Insulin resistance (HP:0000855) | 2.20823339 |
73 | Hypomagnesemia (HP:0002917) | 2.15858133 |
74 | Papilledema (HP:0001085) | 2.14593776 |
75 | Exocrine pancreatic insufficiency (HP:0001738) | 2.14002377 |
76 | Retinal dysplasia (HP:0007973) | 2.13657310 |
77 | Hyperkalemia (HP:0002153) | 2.11301630 |
78 | Neoplasm of the adrenal gland (HP:0100631) | 2.11090797 |
79 | Hyperphosphatemia (HP:0002905) | 2.10484670 |
80 | Progressive macrocephaly (HP:0004481) | 2.10457138 |
81 | Abnormality of the fovea (HP:0000493) | 2.10428096 |
82 | Metabolic alkalosis (HP:0200114) | 2.10210619 |
83 | Gastrointestinal atresia (HP:0002589) | 2.09150083 |
84 | Testicular neoplasm (HP:0010788) | 2.09009318 |
85 | Peripheral hypomyelination (HP:0007182) | 2.08387134 |
86 | Hepatoblastoma (HP:0002884) | 2.07723420 |
87 | Abnormality of vitamin metabolism (HP:0100508) | 2.07389086 |
88 | Megalencephaly (HP:0001355) | 2.06727217 |
89 | Nephronophthisis (HP:0000090) | 2.04130208 |
90 | Constricted visual fields (HP:0001133) | 2.02242725 |
91 | Anxiety (HP:0000739) | 2.01843437 |
92 | Intestinal atresia (HP:0011100) | 2.01361698 |
93 | Downturned corners of mouth (HP:0002714) | 2.00611573 |
94 | Abnormality of the renal cortex (HP:0011035) | 2.00419489 |
95 | Furrowed tongue (HP:0000221) | 1.99818035 |
96 | Menstrual irregularities (HP:0000858) | 1.99681252 |
97 | Pancreatic fibrosis (HP:0100732) | 1.98983195 |
98 | Muscular hypotonia of the trunk (HP:0008936) | 1.97659119 |
99 | Postural tremor (HP:0002174) | 1.97337682 |
100 | Decreased lacrimation (HP:0000633) | 1.97184230 |
101 | Pancreatic cysts (HP:0001737) | 1.96521808 |
102 | Vascular calcification (HP:0004934) | 1.94908985 |
103 | Gait imbalance (HP:0002141) | 1.94584507 |
104 | Gaze-evoked nystagmus (HP:0000640) | 1.94231792 |
105 | Restlessness (HP:0000711) | 1.89924942 |
106 | Dysautonomia (HP:0002459) | 1.89441108 |
107 | Methylmalonic acidemia (HP:0002912) | 1.89323800 |
108 | Abnormality of the metopic suture (HP:0005556) | 1.89161685 |
109 | Abnormality of magnesium homeostasis (HP:0004921) | 1.88966203 |
110 | True hermaphroditism (HP:0010459) | 1.87830335 |
111 | Type I diabetes mellitus (HP:0100651) | 1.87686812 |
112 | Generalized tonic-clonic seizures (HP:0002069) | 1.86897459 |
113 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.86519435 |
114 | Generalized aminoaciduria (HP:0002909) | 1.85997550 |
115 | Ketosis (HP:0001946) | 1.84486698 |
116 | Tubular atrophy (HP:0000092) | 1.84356906 |
117 | Type II lissencephaly (HP:0007260) | 1.84141865 |
118 | Hypokinesia (HP:0002375) | 1.83718124 |
119 | Truncal obesity (HP:0001956) | 1.83073115 |
120 | Bone cyst (HP:0012062) | 1.82632739 |
121 | Congenital primary aphakia (HP:0007707) | 1.81703083 |
122 | Abdominal distention (HP:0003270) | 1.81411185 |
123 | Congenital stationary night blindness (HP:0007642) | 1.81251886 |
124 | Macroorchidism (HP:0000053) | 1.79571518 |
125 | Goiter (HP:0000853) | 1.79182296 |
126 | Progressive cerebellar ataxia (HP:0002073) | 1.78211019 |
127 | Attenuation of retinal blood vessels (HP:0007843) | 1.77246621 |
128 | Sensory axonal neuropathy (HP:0003390) | 1.76800813 |
129 | Hypothermia (HP:0002045) | 1.76036878 |
130 | Focal motor seizures (HP:0011153) | 1.74676579 |
131 | Increased CSF protein (HP:0002922) | 1.74557412 |
132 | Absence seizures (HP:0002121) | 1.74350743 |
133 | Proximal tubulopathy (HP:0000114) | 1.74329791 |
134 | Metaphyseal dysplasia (HP:0100255) | 1.74267266 |
135 | Dialeptic seizures (HP:0011146) | 1.73973526 |
136 | Cerebral hypomyelination (HP:0006808) | 1.72419797 |
137 | Disproportionate short-trunk short stature (HP:0003521) | 1.72129595 |
138 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.72020149 |
139 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71194796 |
140 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71194796 |
141 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71194796 |
142 | Hypoalbuminemia (HP:0003073) | 1.70645895 |
143 | Abnormal albumin level (HP:0012116) | 1.70645895 |
144 | Febrile seizures (HP:0002373) | 1.70505877 |
145 | Glycosuria (HP:0003076) | 1.70440728 |
146 | Abnormality of urine glucose concentration (HP:0011016) | 1.70440728 |
147 | Abnormality of midbrain morphology (HP:0002418) | 1.70430973 |
148 | Molar tooth sign on MRI (HP:0002419) | 1.70430973 |
149 | Hyperphosphaturia (HP:0003109) | 1.69306149 |
150 | Turricephaly (HP:0000262) | 1.67998431 |
151 | Polydipsia (HP:0001959) | 1.66490646 |
152 | Abnormal drinking behavior (HP:0030082) | 1.66490646 |
153 | Spastic gait (HP:0002064) | 1.65853076 |
154 | Hypophosphatemia (HP:0002148) | 1.64521201 |
155 | Abnormal protein glycosylation (HP:0012346) | 1.64272664 |
156 | Abnormal glycosylation (HP:0012345) | 1.64272664 |
157 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.64272664 |
158 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.64272664 |
159 | Abnormality of the intrinsic pathway (HP:0010989) | 1.61655107 |
160 | Ankle clonus (HP:0011448) | 1.61605839 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K9 | 5.89040518 |
2 | INSRR | 5.48621623 |
3 | PASK | 4.93300583 |
4 | MAPK15 | 4.27641011 |
5 | WNK4 | 3.38665770 |
6 | TAOK3 | 2.94371090 |
7 | HIPK2 | 2.76518557 |
8 | STK39 | 2.74329032 |
9 | PRKD3 | 2.65989627 |
10 | UHMK1 | 2.55809368 |
11 | DAPK2 | 2.34824702 |
12 | MAP3K2 | 2.12625547 |
13 | NTRK1 | 2.09368778 |
14 | WNK3 | 2.02391130 |
15 | MAP4K2 | 1.98955560 |
16 | EPHB1 | 1.95510426 |
17 | MET | 1.88981640 |
18 | GRK1 | 1.86220855 |
19 | OXSR1 | 1.74489948 |
20 | WNK1 | 1.73714187 |
21 | ADRBK2 | 1.69509999 |
22 | FGFR3 | 1.61964888 |
23 | MAP3K1 | 1.51591799 |
24 | BCR | 1.50744847 |
25 | PKN1 | 1.46921260 |
26 | NTRK3 | 1.46423223 |
27 | FRK | 1.45381290 |
28 | ACVR1B | 1.45356551 |
29 | MAPKAPK5 | 1.41170485 |
30 | MAP2K6 | 1.38675031 |
31 | PINK1 | 1.28984114 |
32 | MAP3K4 | 1.27583542 |
33 | PRKCG | 1.25727353 |
34 | IRAK1 | 1.22741929 |
35 | CAMK2D | 1.18533744 |
36 | FGFR2 | 1.18484456 |
37 | CAMK2B | 1.16501447 |
38 | CASK | 1.16349264 |
39 | IRAK2 | 1.15514314 |
40 | PAK3 | 1.15318183 |
41 | NEK6 | 1.14897929 |
42 | PRKCH | 1.13700589 |
43 | PRKD2 | 1.12754833 |
44 | CDC42BPA | 1.11025462 |
45 | NLK | 1.10830131 |
46 | TAF1 | 1.09983767 |
47 | CSNK1A1L | 1.01496326 |
48 | CAMKK2 | 1.01492394 |
49 | TNIK | 1.01372368 |
50 | MARK2 | 0.97945830 |
51 | SGK2 | 0.96846653 |
52 | PIK3CG | 0.96651284 |
53 | MAP2K2 | 0.96642499 |
54 | PTK2 | 0.96073581 |
55 | PNCK | 0.89291774 |
56 | PRKD1 | 0.88768343 |
57 | SGK223 | 0.88245732 |
58 | SGK494 | 0.88245732 |
59 | PRKCE | 0.87859611 |
60 | EPHA3 | 0.84828031 |
61 | CSNK1G3 | 0.84454248 |
62 | GSK3A | 0.81733493 |
63 | PLK2 | 0.81329081 |
64 | DYRK1B | 0.78781459 |
65 | CSNK1G2 | 0.77626898 |
66 | IRAK3 | 0.76884005 |
67 | EIF2AK3 | 0.74388447 |
68 | TSSK6 | 0.72412475 |
69 | PTK6 | 0.72266477 |
70 | CSNK1G1 | 0.72159286 |
71 | BMPR1B | 0.71695795 |
72 | TYRO3 | 0.70744710 |
73 | ERN1 | 0.69588943 |
74 | STK3 | 0.69376160 |
75 | MARK1 | 0.68348948 |
76 | PDGFRA | 0.67307744 |
77 | MAPK13 | 0.65687147 |
78 | CDK3 | 0.65066878 |
79 | LIMK1 | 0.64506074 |
80 | MST4 | 0.64164635 |
81 | CDK5 | 0.63860560 |
82 | STK38L | 0.60453290 |
83 | TNK2 | 0.59264044 |
84 | STK11 | 0.56736915 |
85 | DYRK2 | 0.55594534 |
86 | MAP2K1 | 0.54781914 |
87 | PDGFRB | 0.54183751 |
88 | TRPM7 | 0.52836693 |
89 | CSNK1A1 | 0.52522109 |
90 | CAMK2G | 0.51542681 |
91 | SIK1 | 0.50438193 |
92 | CAMK2A | 0.49828187 |
93 | RET | 0.49532111 |
94 | PAK6 | 0.48622772 |
95 | TAOK1 | 0.48397355 |
96 | ITK | 0.48144897 |
97 | PRKAA2 | 0.46988463 |
98 | MKNK2 | 0.45064407 |
99 | SGK3 | 0.44694383 |
100 | YES1 | 0.44374948 |
101 | SCYL2 | 0.41694455 |
102 | BMPR2 | 0.41544213 |
103 | SGK1 | 0.41455202 |
104 | DDR2 | 0.41370144 |
105 | PTK2B | 0.41217481 |
106 | PDPK1 | 0.40491951 |
107 | MAP3K7 | 0.40358771 |
108 | PRKACA | 0.40239892 |
109 | PRKG1 | 0.39003013 |
110 | CAMK1G | 0.37886610 |
111 | BRAF | 0.37873198 |
112 | FER | 0.37788609 |
113 | BRSK2 | 0.37771221 |
114 | MAP2K7 | 0.37724364 |
115 | BRD4 | 0.37474860 |
116 | NTRK2 | 0.37418782 |
117 | NME1 | 0.37407915 |
118 | EPHA4 | 0.37315712 |
119 | CAMKK1 | 0.36423236 |
120 | FLT3 | 0.35154784 |
121 | PHKG2 | 0.35038105 |
122 | PHKG1 | 0.35038105 |
123 | DYRK1A | 0.34970809 |
124 | KSR2 | 0.34785884 |
125 | PRKCI | 0.34615014 |
126 | ADRBK1 | 0.34202931 |
127 | PRKCZ | 0.31959874 |
128 | PRKAA1 | 0.31281430 |
129 | AKT3 | 0.30847127 |
130 | RPS6KA5 | 0.30772299 |
131 | CSNK1D | 0.30691735 |
132 | PRKACG | 0.29745866 |
133 | PRKDC | 0.28959953 |
134 | CSNK1E | 0.28294058 |
135 | ARAF | 0.28168577 |
136 | STK4 | 0.27853699 |
137 | BCKDK | 0.27650742 |
138 | PRKACB | 0.27399827 |
139 | ROCK1 | 0.27253306 |
140 | PBK | 0.26350768 |
141 | ERBB3 | 0.26270205 |
142 | MAPK10 | 0.25292660 |
143 | FYN | 0.25044313 |
144 | PRKCA | 0.24565192 |
145 | CDK19 | 0.24322253 |
146 | RPS6KA3 | 0.24023729 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.56932586 |
2 | Protein export_Homo sapiens_hsa03060 | 5.34771967 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.47217169 |
4 | Insulin secretion_Homo sapiens_hsa04911 | 3.01473596 |
5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.49363547 |
6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.18101586 |
7 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.03441339 |
8 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.00698095 |
9 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.95610417 |
10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.90679495 |
11 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.90359708 |
12 | Cocaine addiction_Homo sapiens_hsa05030 | 1.84131941 |
13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.83130365 |
14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.80964051 |
15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.75804184 |
16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.70939843 |
17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.70370085 |
18 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.62784880 |
19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.54151349 |
20 | Lysosome_Homo sapiens_hsa04142 | 1.48317755 |
21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.47614595 |
22 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.38744567 |
23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.37210282 |
24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32887471 |
25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.30821169 |
26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30542478 |
27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.21578418 |
28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21308397 |
29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17049232 |
30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.15696449 |
31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15104649 |
32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09776893 |
33 | Phototransduction_Homo sapiens_hsa04744 | 1.07687974 |
34 | Mineral absorption_Homo sapiens_hsa04978 | 1.04468944 |
35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02701889 |
36 | Taste transduction_Homo sapiens_hsa04742 | 1.02661899 |
37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02511492 |
38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.00772066 |
39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98289519 |
40 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96137575 |
41 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94055172 |
42 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93473155 |
43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93269686 |
44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90277782 |
45 | Circadian entrainment_Homo sapiens_hsa04713 | 0.89422707 |
46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89259761 |
47 | Peroxisome_Homo sapiens_hsa04146 | 0.85231262 |
48 | Prion diseases_Homo sapiens_hsa05020 | 0.84190333 |
49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83375175 |
50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82844039 |
51 | Morphine addiction_Homo sapiens_hsa05032 | 0.81219446 |
52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79962160 |
53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79476297 |
54 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78796302 |
55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78481023 |
56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77817116 |
57 | ABC transporters_Homo sapiens_hsa02010 | 0.77810616 |
58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77166570 |
59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76188154 |
60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.76002926 |
61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74323762 |
62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74184615 |
63 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73847290 |
64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71753730 |
65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70840843 |
66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69803362 |
67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.68916571 |
68 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67117902 |
69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.66661644 |
70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64994475 |
71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64929956 |
72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64908514 |
73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64857942 |
74 | Long-term depression_Homo sapiens_hsa04730 | 0.64664423 |
75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.62589501 |
76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62358368 |
77 | Renin secretion_Homo sapiens_hsa04924 | 0.59931503 |
78 | Bile secretion_Homo sapiens_hsa04976 | 0.58197838 |
79 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57888488 |
80 | Long-term potentiation_Homo sapiens_hsa04720 | 0.57388518 |
81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.57030455 |
82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56083667 |
83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53947353 |
84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53374521 |
85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51910376 |
86 | Alcoholism_Homo sapiens_hsa05034 | 0.50795202 |
87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48947766 |
88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48432214 |
89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47609449 |
90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46117631 |
91 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45966008 |
92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45739250 |
93 | Gap junction_Homo sapiens_hsa04540 | 0.45713038 |
94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45353103 |
95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45117174 |
96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44759313 |
97 | Insulin resistance_Homo sapiens_hsa04931 | 0.44652939 |
98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44059648 |
99 | Melanogenesis_Homo sapiens_hsa04916 | 0.43664542 |
100 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42863323 |
101 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42318709 |
102 | Axon guidance_Homo sapiens_hsa04360 | 0.41895242 |
103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41493754 |
104 | Olfactory transduction_Homo sapiens_hsa04740 | 0.40471700 |
105 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40182151 |
106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.38821513 |
107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37985816 |
108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37380581 |
109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.36727117 |
110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36444908 |
111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34284253 |
112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34283433 |
113 | Prostate cancer_Homo sapiens_hsa05215 | 0.33973801 |
114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33826863 |
115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33142819 |
116 | Salivary secretion_Homo sapiens_hsa04970 | 0.32833901 |
117 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31952106 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31344630 |
119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31081574 |
120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31038710 |
121 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.30263156 |
122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30200139 |
123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29366249 |
124 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28939179 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.25961302 |
126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25451146 |
127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24876981 |
128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.24855078 |
129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23795681 |